• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Inappropriate Shocks in Brugada Syndrome Patients With a Subcutaneous Implantable Cardioverter Defibrillator.

作者信息

Watanabe Masaya, Nanbu Tadafumi, Ishidoya Yuki, Suzuki George, Yotsukura Akihiko, Yoshida Izumi, Tanaka Yoshitaka, Inoue Kazushige, Mitsuishi Junko, Kanno Tomomi, Sakurai Masayuki, Anzai Toshihisa

机构信息

Department of Cardiovascular Medicine, Hokko Memorial Hospital, Sapporo, Japan.

Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

出版信息

Pacing Clin Electrophysiol. 2025 Feb;48(2):160-168. doi: 10.1111/pace.15151. Epub 2025 Jan 27.

DOI:10.1111/pace.15151
PMID:39871409
Abstract

BACKGROUND

This study aimed to compare inappropriate shock (IAS) rates between subcutaneous implantable cardioverter-defibrillator (S-ICD) and transvenous ICD (TV-ICD) in Brugada syndrome (BrS) patients and identify risk factors for IAS in S-ICD use.

METHODS

We enrolled consecutive patients with BrS who underwent ICD implantation between 2013 and 2023. Data on clinical characteristics, S-ICD screening test data, and IAS occurrence were retrospectively analyzed.

RESULTS

In total, 74 patients (40 with S-ICDs and 34 with TV-ICD) were enrolled in the study. During a median follow-up of 4.6 years, IAS occurred in nine S-ICD and three TV-ICD patients, exhibiting a non-statistically significant trend (log-rank p = 0.103) toward a higher incidence in the S-ICD group. The incidence of IAS related to non-atrial tachyarrhythmia (non-AT) causes was significantly higher in the S-ICD group than in the TV-ICD group (log-rank p = 0.014). Fewer electrocardiography (ECG) sensing vectors passing the screening test at both the baseline and exercise test (hazard ratio [HR] 0.31, 95% confidence interval [CI] 0.09-0.85; p = 0.21) and detection of ATs (HR 5.25, 95% CI 1.15-24.05; p = -0.048) were associated with IAS in patients with S-ICD.

CONCLUSION

No significant difference was observed in the overall incidence of IAS between the S-ICD and TV-ICD groups; however, IAS due to non-AT causes occurred more frequently in the S-ICD group. Fewer ECG sensing vectors passing screening were significantly correlated with the IAS when exercise test results were considered. Therefore, ECG screening, including exercise testing, is preferable for S-ICD candidates.

摘要

相似文献

1
Inappropriate Shocks in Brugada Syndrome Patients With a Subcutaneous Implantable Cardioverter Defibrillator.
Pacing Clin Electrophysiol. 2025 Feb;48(2):160-168. doi: 10.1111/pace.15151. Epub 2025 Jan 27.
2
Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.皮下植入式心脏复律除颤器治疗 Brugada 综合征患者的有效性。
Heart Vessels. 2021 Feb;36(2):260-266. doi: 10.1007/s00380-020-01683-0. Epub 2020 Aug 24.
3
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.药物诱导 1 型 ECG 图形 Brugada 综合征患者中皮下与经静脉植入式心脏复律除颤器的比较:来自 IBRYD 研究的倾向评分匹配分析。
Heart Vessels. 2023 May;38(5):680-688. doi: 10.1007/s00380-022-02204-x. Epub 2022 Nov 24.
4
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.皮下与经静脉植入式心脏除颤器的不适当治疗及电击率:PRAETORIAN试验的二次分析
Circ Arrhythm Electrophysiol. 2024 Dec;17(12):e012836. doi: 10.1161/CIRCEP.124.012836. Epub 2024 Dec 3.
5
Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.运动负荷试验显示,布加综合征患者不适合植入皮下植入式心律转复除颤器。
J Cardiovasc Electrophysiol. 2017 Dec;28(12):1454-1459. doi: 10.1111/jce.13315. Epub 2017 Sep 1.
6
Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.药物激发试验期间心电图筛查对预测 Brugada 综合征患者皮下植入式心律转复除颤器 T 波过度感知的影响。
Heart Vessels. 2017 Oct;32(10):1277-1283. doi: 10.1007/s00380-017-0994-3. Epub 2017 May 18.
7
Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator.预测植入式皮下心脏除颤器的 Brugada 综合征患者不合理电击的因素。
J Cardiovasc Electrophysiol. 2021 Jun;32(6):1704-1711. doi: 10.1111/jce.15059. Epub 2021 May 5.
8
Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.SMART Pass 滤器对阿义马林诱导 Brugada 综合征和皮下植入式心脏复律除颤器植入失败患者的影响:前瞻性多中心研究结果。
Europace. 2022 May 3;24(5):845-854. doi: 10.1093/europace/euab230.
9
Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.皮下与经静脉植入式除颤器治疗的长期临床结果。
J Am Coll Cardiol. 2016 Nov 8;68(19):2047-2055. doi: 10.1016/j.jacc.2016.08.044.
10
Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.肥厚型心肌病患者皮下植入式心律转复除颤器中的适当和不适当电击:一项国际多中心研究。
Heart Rhythm. 2020 Jul;17(7):1107-1114. doi: 10.1016/j.hrthm.2020.02.008. Epub 2020 Feb 18.